Skip to main content

Epizyme, Inc.

EPZMDelisted Aug 12, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001571498

Epizyme, Inc. was delisted on Aug 12, 2022; its insiders filed their last Form 4 on Aug 16, 2022; 94 institutions reported holding it in 13F filings for Q2 2022, worth $187.0M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Epizyme, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of EPZM: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1161132+17
Shares93.7M3.84M84.8M−5.06M (−5.6%)
Value$479.9M$19.7M$212.1M−$248.1M (−53.9%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held Epizyme, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to EPZM in Q4 2021
InstitutionSharesValue% of portfolio
Jacobs Levy Equity Management, Inc587,164$1.47M0.01%
Renaissance Technologies LLC509,188$1.27M0.00%
Healthcare of Ontario Pension Plan Trust Fund403,200$1.01M0.00%
ExodusPoint Capital Management, LP359,472$899.0K0.01%
Two Sigma Advisers, LP315,400$789.0K0.00%
Qube Research & Technologies Ltd293,126$733.0K0.01%
D. E. Shaw & Co., Inc.259,522$649.0K0.00%
Toronto Dominion Bank213,121$533.0K0.00%
Nomura Holdings Inc203,197$509.0K0.00%
Tudor Investment Corp Et Al142,647$357.0K0.01%
Ergoteles LLC129,782$324.0K0.01%
Squarepoint Ops LLC100,416$251.0K0.00%
Graham Capital Management, L.P.74,219$185.0K0.01%
Connor, Clark & Lunn Investment Management Ltd.64,493$161.0K0.00%
Engineers Gate Manager LP55,116$138.0K0.01%
Algert Global LLC54,360$136.0K0.02%
Alpine Global Management, LLC49,392$123.0K0.02%
Quantbot Technologies LP44,877$112.0K0.01%
Virtu Financial LLC42,750$107.0K0.01%
Walleye Capital LLC35,478$89.0K0.00%
PDT Partners, LLC31,115$78.0K0.01%
Caxton Associates LP30,300$76.0K0.01%
Balyasny Asset Management LLC25,990$65.0K0.00%
AQR Capital Management LLC18,243$46.0K0.00%
Group One Trading, L.P.17,539$44.0K0.00%
Landscape Capital Management, L.L.C.16,100$40.0K0.01%
Bayesian Capital Management, LP15,911$40.0K0.01%
Occudo Quantitative Strategies LP15,963$40.0K0.00%
Janus Henderson Group PLC14,529$36.0K0.00%
Boothbay Fund Management, LLC13,948$35.0K0.00%
Pinnacle Wealth Planning Services, Inc.12,428$31.0K0.01%
Kraematon Investment Advisors, Inc11,200$28.0K0.03%
Paloma Partners Management Co10,775$27.0K0.00%
XTX Topco Ltd10,756$27.0K0.02%
Eagle Bay Advisors LLC1,865$5.00K0.00%
Signaturefd, LLC565$1.00K0.00%
Glassman Wealth Services300$1.00K0.00%

Sold out (20)

Institutions that held Epizyme, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Not filed for Q4 2021 yet (1)

Institutions that held Epizyme, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EPZM in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
KPCB XIII Associates, LLC3,838,166$19.7M